Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2056 to 2070 of 8219 results

  1. High linear energy transfer radiation for carbon ion beam therapy

    Topic prioritisation

  2. Lymphatico-venous anastomosis for chronic lymphoedema

    Topic prioritisation

  3. Oesophageal String Test

    Topic prioritisation

  4. Transcatheter Tricuspid Valve Replacement

    Topic prioritisation

  5. Infrared lasers for treating onychomycosis

    Topic prioritisation

  6. Intradiscal oxygen-ozone treatment of symptomatic lumbar disc herniation

    Topic prioritisation

  7. Transoral Endoscopic Thyroid/Parathyroid Vestibular Approach

    Topic prioritisation

  8. Extra-vascular implantable cardioverter defibrillator (EVICD) for people with a defibrillator

    Awaiting development Reference number: GID-IPG10437 Expected publication date: TBC

  9. Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy (review of TA673) [ID6403]

    In development Reference number: GID-TA11675 Expected publication date: TBC

  10. Delandistrogene moxeparvovec for treating Duchenne muscular dystrophy in children 4 to 7 years ID3897

    In development Reference number: GID-TA11437 Expected publication date: TBC

  11. Itepekimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6547]

    In development Reference number: GID-TA11716 Expected publication date: TBC

  12. Osteoporosis

    In development Reference number: GID-QS10188 Expected publication date: TBC

  13. Deutetrabenazine for treating tardive dyskinesia ID6550

    In development Reference number: GID-TA11718 Expected publication date: TBC

  14. Ruxolitinib for treating moderate atopic dermatitis [ID6602]

    Awaiting development Reference number: GID-TA11809 Expected publication date: TBC

  15. Trastuzumab deruxtecan for untreated HER2-mutated unresectable advanced non-small-cell lung cancer [ID6603]

    Awaiting development Reference number: GID-TA11706 Expected publication date: TBC